HOME > TOP STORIES
TOP STORIES
-
BUSINESS ASKA to Accelerate Innovative Pharma Biz, Not Generics; President Sees Trivial Impact from Follow-On Blopress AG
August 25, 2021
-
REGULATORY Pharma Leaders Support Draft Industry Vision, but Stress Need for Price Maintenance of Patented Meds: Confab
August 25, 2021
-
ORGANIZATION EFPIA Japan Appoints Sanofi’s Takahiko Iwaya as New Chair
August 25, 2021
-
BUSINESS Drug Makers’ Q1 Operating Profits Eclipsing Projections on One-Time Gains, Product Growth
August 24, 2021
-
REGULATORY PAFSC to Review Astellas’ Padcev, Pfizer’s JAK Inhibitor, AZ’s Lupus Drug and More
August 24, 2021
-
REGULATORY Takeda’s 1st Cell Therapy Up for PAFSC Review on Sept. 6
August 24, 2021
-
REGULATORY New Pharma Vision to Set Out Clear Goal, KPIs after Lawmaker Calls
August 23, 2021
-
REGULATORY Sharp Drop in Suspected Violations Seen in FY2020 Drug Promotion, but Comparison Difficult due to COVID-19: MHLW
August 23, 2021
-
ORGANIZATION New Established Drugs’ Group Places Top Priority on Stable Generic Supply; Research-Driven and Foreign Firms to Join
August 20, 2021
-
BUSINESS Yamasa Ramps Up API CMO Biz for Oligonucleotides, mRNA Drugs amid Changes in Modalities
August 19, 2021
-
BUSINESS Choseido Likely to Face Administrative Penalty over Manufacturing Flaws
August 18, 2021
-
BUSINESS Japan Pharma Market Delivers 1st Growth in 5 Qtrs in April-June: IQVIA
August 18, 2021
-
REGULATORY 14 Firms Flock to Get Approval for E Keppra Generics towards December Listing
August 17, 2021
-
ACADEMIA Evrysdi Debut Expands SMA Treatment Options, Improved Use Expected for All 3 Drugs: Professor
August 16, 2021
-
BUSINESS Probe Panel Urges Ono to Establish Foundation to Handle Scholarship Donations after Bribery Case
August 16, 2021
-
BUSINESS Evrysdi, Aimovig Now Available; Veklury’s Normal Distribution to Start around October
August 13, 2021
-
BUSINESS Morimoto Pharma Aims at Commercial Production of Freeze-Dried Vaccine in FY2022
August 12, 2021
-
BUSINESS Orizuru Therapeutics Boots Up to Take Over iPSC Assets from T-CiRA, Eyes IPO in 2026
August 11, 2021
-
BUSINESS HIF-PH Drugs’ Sluggish Q1 Sales Signal Tepid Uptake as Side Effect Concerns Weigh
August 10, 2021
-
BUSINESS Foreign Drug Makers Scrapping Sales Offices as Sanofi Follows GSK, Novartis, AZ
August 6, 2021
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
